Cetuximab plus chemoradiation combined therapy for locally advanced inoperable pancreatic adenocarcima: A phase I study

4629 Background: Chemoradiation using gemcitabine is an active therapy in advanced pancreatic cancer. Cetuximab is a potent radiosensitizer. This phase I study aims to evaluate the feasability and ...